As the COVID-19 pandemic continues to linger, more data are becoming available about what possible links there may be between COVID-19 infection in pregnancy and risks to mothers and their babies. In this study, research teams from around the world came together to study pregnant women with COVID-19 infection to ask what outcomes in mothers or their babies could be linked to COVID-19. Researchers found the risk for preeclampsia was 76% higher in a study group of 706 women who had COVID-19 during pregnancy (compared to a group of pregnant women without COVID-19 diagnosis). In a smaller analysis in their study of only pregnant women with COVID-19 infection but without any symptoms (i.e., asymptomatic), researchers still found a 63% increased risk for preeclampsia in the asymptomatic women. Researchers also found increased risks for severe infection and preterm birth in women with COVID-19 infection in pregnancy. Studies like these are important to understand how COVID-19 illness may affect pregnant women and can be taken into account when making decisions about social distancing, masking, and vaccination.
LINK: https://pubmed.ncbi.nlm.nih.gov/33885740/
Each quarter, our team of researchers reviews the most current studies related to hypertensive disorders of pregnancy and selects those studies they feel will be of greatest interest to our community to summarize.
Special thanks to our volunteer research team, who under the leadership of Dr. Elizabeth Sutton, make Research Roundup possible: Alisse Hauspurg, MD Felicia LeMoine, MD Jenny Sones, PhD, DVM, and Robin Trupp, PhD, RN.
Your story is needed to improve outcomes for moms like you. Add your voice to critical preeclampsia research to ensure that every story is heard.
Frequently asked questions about the Preeclampsia Registry, a patient-driven registry and biobank.
The Preeclampsia Foundation offers research funding, study recruitment, and other patient engagement services to researchers.
We provide research grant funding to advance progress towards detection, prevention, or treatment of preeclampsia, HELLP syndrome, and other hypertensive disorders of pregnancy.
While the foundations of preeclampsia are believed to develop in the early stages of pregnancy, the current screening process occurs at 20 weeks, nearly half way through the second trimester. When cli...
Research suggests that preeclampsia may develop in a two-stage process. The first stage involves challenges to the way that the placenta implants and grows. In a normal pregnancy, a type of placental...
The risk of developing hypertension and cardiovascular disease (CVD) significantly increases for patients who experience gestational hypertension, preeclampsia, or other hypertensive disorders of preg...
Cerebral complications from preeclampsia and eclampsia are a major cause of maternal mortality and long-term neurological impact. Understanding pathophysiology (changes in how the body works as a resu...
A new research study suggests that blood pressure changes during the first 20 weeks of pregnancy—called blood pressure trajectories—may give providers a peek at a woman’s risk of dev...